HEMATOLOGIC, CLINICAL, AND CYTOGENETIC ANALYSIS IN 109 PATIENTS WITH PRIMARY MYELODYSPLASTIC-SYNDROME - PROGNOSTIC-SIGNIFICANCE OF MORPHOLOGY AND CHROMOSOME FINDINGS

被引:59
作者
PARLIER, V
VANMELLE, G
BERIS, P
SCHMIDT, P
TOBLER, A
HALLER, E
BELLOMO, MJ
机构
[1] CHU VAUDOIS,DIV MED GENET,CH-1011 LAUSANNE,SWITZERLAND
[2] CHU VAUDOIS,DIV HEMATOL,CH-1011 LAUSANNE,SWITZERLAND
[3] UNIV LAUSANNE,INST SOCIAL & PREVENT MED,LAUSANNE,SWITZERLAND
[4] HOP CANTONAL UNIV GENEVA,DIV HEMATOL,GENEVA,SWITZERLAND
[5] INSELSPITAL BERN,HAMATOL ZENT LAB,BERN,SWITZERLAND
关键词
D O I
10.1016/0165-4608(94)90094-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
One hundred and nine patients with primary myelodysplastic syndrome (MDS) were classified according to the French-American-British (FAB) criteria: 27 refractory anemia (RA, 25%), 26 RA with ringed sideroblasts (RARS, 24%), 16 RA with excess of blasts (RAEB, 15%), 10 RAEB in transformation (RAEB-t, 9%), 25 chronic myelomonocytic leukemia (CMMoL, 23%), and five unclassifiable MDS (4%). Forty-three were women and 66 were men (sex ratio 2:3). Age ranged from 30-92 years (mean 69 years) with nine patients aged less than 50 years (8%). A cytogenetic result was obtained in all cases. At initial study, a chromosome defect was observed in 56% of patients. Rates of abnormality depended on FAB subtype: 52% in RA, 100% in RA 5q-, 50% in RARS, 56% in RAEB, 70% in RAEB-t and 44% in CMMoL. The most frequent single defects were del(5q), -7/del/(7q), del(20q), Y loss, and +8. Except for the 5q syndrome entity, specific chromosome defects were not associated with particular FAB subtypes. Bone marrow (BM) insufficiency (22%) and leukemic transformation (21%) were the most important causes of death. The rate of leukemic transformation increased with the number of dysplastic BM cell lineages and was also associated with karyotype complexity and the proportion of abnormal/normal metaphases. The longest median survivals were observed in BARS (142 months) and RA/RA5q- (91 months) types. Median survivals decreased with increasing Bournemouth score values. Patients with three abnormal cell lineages had a median survival shorter than those with one or two abnormal lineages. Similarly patients with complex defects had shorter survival than those with single or double defects or a normal karyotype. There was no statistically significant difference between survival of NN (normal), AN (abnormal/normal), and AA patients or between survival of patients with del(5q), -7/del(7q), +8 or del(20q).
引用
收藏
页码:219 / 231
页数:13
相关论文
共 76 条
[1]   THE PROGNOSTIC VALUE OF CHROMOSOME-STUDIES IN PATIENTS WITH THE PRELEUKEMIC SYNDROME (HEMATOPOIETIC DYSPLASIA) [J].
ANDERSON, RL ;
BAGBY, GC .
LEUKEMIA RESEARCH, 1982, 6 (02) :175-181
[2]  
ARTHUR DC, 1989, LEUKEMIA, V3, P833
[3]   CYTOGENETIC STUDY OF 88 CASES OF REFRACTORY-ANEMIA [J].
AYRAUD, N ;
DONZEAU, M ;
RAYNAUD, S ;
LAMBERT, JC .
CANCER GENETICS AND CYTOGENETICS, 1983, 8 (03) :243-248
[4]   3 NEW CASES OF CHROMOSOME-3 REARRANGEMENT IN BAND-Q21 AND BAND-Q26 WITH ABNORMAL THROMBOPOIESIS BRING FURTHER EVIDENCE TO THE EXISTENCE OF A 3Q21Q26-SYNDROME [J].
BELLOMO, MJ ;
PARLIER, V ;
MUHLEMATTER, D ;
GROB, JP ;
BERIS, P .
CANCER GENETICS AND CYTOGENETICS, 1992, 59 (02) :138-160
[5]  
BELLOMO MJ, 1990, CANCER GENET CYTOGEN, V46, P157
[6]  
BELLOMO MJ, 1990, CANCER GENET CYTOGEN, V44, P271
[7]   KARYOTYPIC EVOLUTION IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES [J].
BENITEZ, J ;
CARBONELL, F ;
FAYOS, JS ;
HEIMPEL, H .
CANCER GENETICS AND CYTOGENETICS, 1985, 16 (02) :157-167
[8]   PROGNOSTIC VALUE OF COMPLEX KARYOTYPES IN PATIENTS WITH SIMPLE REFRACTORY-ANEMIA [J].
BENITEZ, J ;
ROUS, GP ;
FAYOS, JS .
CANCER GENETICS AND CYTOGENETICS, 1991, 53 (02) :279-280
[9]   PROPOSALS FOR THE CLASSIFICATION OF THE MYELODYSPLASTIC SYNDROMES [J].
BENNETT, JM ;
CATOVSKY, D ;
DANIEL, MT ;
FLANDRIN, G ;
GALTON, DAG ;
GRALNICK, HR ;
SULTAN, C .
BRITISH JOURNAL OF HAEMATOLOGY, 1982, 51 (02) :189-199
[10]   PROPOSED REVISED CRITERIA FOR THE CLASSIFICATION OF ACUTE MYELOID-LEUKEMIA - A REPORT OF THE FRENCH-AMERICAN-BRITISH COOPERATIVE GROUP [J].
BENNETT, JM ;
CATOVSKY, D ;
DANIEL, MT ;
FLANDRIN, G ;
GALTON, DAG ;
GRALNICK, HR ;
SULTAN, C .
ANNALS OF INTERNAL MEDICINE, 1985, 103 (04) :620-625